Susan Hasty, Publisher
Table of Contents . . . July 9th, 2005
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Cancer Law Weekly | Other Publications
Aphton Corporation - Biotech company appoints Manfred Ruediger as chief operating officer
Avantogen - European patent grant for immune-enhancing adjuvant
Cel-Sci Corp. - U.S. patent allowed on pre-sensitizing cancer prior to treatment
European Society for Human Genetics - Geneticists oppose singling out Jewish women in European patent
Exelixis, Inc. - Collaboration to focus on therapeutics for cancer, inflammation, tissue repair
Kosan Biosciences - Trial of second-generation Hsp90 inhibitor in hematologic cancers initiated
Lorus Therapeutics Inc. - European Patent Office grants patent allowance to protect anticancer drug
North Carolina Cancer Ctr. - Exposure to sunlight may decrease risk of prostate cancer
Theragenics Corporation - Cancer device companies announce settlement of arbitration by mutual consent
University of Edinburgh - Doctors argue for new ways to resolve health treatment choices
AVI BioPharma, Inc. - Positive results reported with Neugene antisense drugs
Abbott - Data reveals a promising new approach in cancer
Affymax, Inc. - Hematide clinical results demonstrate potent effect on red blood cell production
Aichi Medical School - Follicular thyroid carcinoma distinguished from adenoma
Allgemeines Krankenhaus Altona - Radiofrequency ablation with osteoplasty can resolve pain
Antigenics, Inc. - Oncophage cancer vaccine gets European orphan drug designation
Antisoma - Agreement signed to manufacture AS1410 for clinical trials
Ariad Pharmaceuticals, Inc. - Company recognized for development of sarcoma treatment
Ascend Therapeutics - Study of 4-hydroxytamoxifen gel published in Journal of Clinical Oncology
Aston University, West Midlands - Findings advance knowledge in pulmonary medicine research
AstraZeneca - Tyrosine kinase inhibitor AZD2171 subdues tumor angiogenesis
Baylor College Med, Houston - Inducible caspase and interleukin-12 combine well to fight prostate cancer
Bioenvision - Clofarabine active in a broad range of hematologic cancers
Bridgeport Hospital - Researchers' findings advance breast cancer research
Brigham & Women's Hospital - Conditions predisposing to anti-MUC1 antibodies protect against ovarian cancer
Case Western Reserve University, Cleveland - Tumor cells take up tailor-made self-assembled polyelectrolyte shells
Cedara Software Corp. - Cedara B-CAD receives U.S. FDA 510(k) clearance
Cedars-Sinai Med. Ctr. - Chemotherapy for brain tumors is boosted after vaccine
Celgene Corporation - REVLIMID new drug application accepted for review by FDA
Cell Genesys Inc. - Findings describe new data in cancer vaccines research
Center Antoine Lacassagne, Nice - Therapeutic options and pattern of local failure after radiotherapy reported
Center Hospitalier de l'Universite de Montreal - Nomogram predicting outcome of prostate biopsy developed
Center Hospitalier de l'Universite de Vaudois - Apoplexy in pituitary macroadenoma described
Centre Hospitalier Intercommunal, Poissy - Pancreatogastrostomy compared to pancreatojejunostomy
Chaim Sheba Medical Center - Multiple subclones identified in TEL-AML1 at diagnosis
Chiba University - Aberrant expression of RAB1A seen in human tongue cancer
Chicago Prostate Cancer Center - New targeted treatment for prostate cancer available in Chicago
Children's Hospital, Cincinnati - Real-time testing distinguishes SYT-SSX rearrangements in synovial sarcomas
Chinese Academy of Sciences, Shanghai - Researchers publish new studies and findings in the area of diagnostics
Cleveland Clinic Foundation - Eruptive nevi of the palms and soles described
Columbia University, New York - Recent findings in cancer screening provide new insights
Columbus Children's Hospital - Selective target can suppress tumor growth
Cooper Institute, Dallas - Diet and exercise reduce migration inhibitory factor in obese subjects
Cross Cancer Institute, Edmonton - Radiation oncology emerging as Canada's premier career choice
Curis, Inc. - Company doses first patient in phase I clinical trial for basal cell carcinoma
Dartmouth Medical School - New advances may slow tumor growth in pancreatic cancer
EMD Lexigen Research Center Corp. - Anti-CD20-IL-2 immunocytokine efficacious in model of human B lymphoma
EXACT Sciences Corp. - Collaboration to evaluate the performance of certain gene methylation markers
European Institute of Oncology, Milan - Cancer immunotherapy based on killing Salmonella-infected tumors
Evanston Northwestern Healthcare, Chicago - Minimally important differences enhanced interpretability of HRQOL scores
Free University of Brussels - Gene-modified dendritic cells from cancer patients activate CTL clones
Fukuoka University - Researchers describe findings in breast cancer studies
GammaCan International, Inc. - Vered Caplan named acting CEO of immunotherapy maker
Genaissance Pharmaceuticals, Inc. - DNA-focused pharma to provide pharmacogenetic support to INC Research
German Cancer Research Center - A new vector system eases DMBT1 variant and full-length cloning
German Cancer Research Center - Red meat found to elevate, fish to lower colorectal cancer risk
German Cancer Research Center, Heidelberg - Steroid receptor function sways glucocorticoid-mediated immunosuppression
Harvard Medical School - New regulators of apoptosis and chemoresistance identified
Harvard University - Basal epithelial phenotype is more frequent in interval breast cancers
Hiroshima University - Apparent diffusion coefficient used to differentiate human brain tumors with MRI
Hokkaido College of Pharmacy - Pharmaceutical management of patients during lung cancer chemotherapy advised
Hospital Clinic University of Santiago - Doppler ultrasonography assessed tumor necrosis after PEI
Huazhong University of Science & Technology - DNA vaccine plus IL-12 enhances anti-angiogenic and antitumor effects
IMPAC Medical Systems, Inc. - IMPAC supports Varian 4D integrated treatment console
Introgen Therapeutics, Inc. - Introgen continues to advance INGN 007 for the treatment of cancer
Introgen Therapeutics, Inc. - Introgen's INGN 241 effective against multiple cancers in preclinical studies
Introgen Therapeutics, Inc. - Research on apoptosis in cancer cell discussed
Istanbul University - Endoscopic and radiologic interventions cited as leading causes of cholangitis
Johns Hopkins Medical Institute - Unexpected additional primary malignancies detected with PET/CT
Kanazawa University, Ishikawa - Ephrin-A1 causes poor outcomes in alpha-fetoprotein-producing liver cancer
Kanazawa University, Ishikawa - Prostaglandin biosynthetic pathway markers augment lung cancer angiogenesis
Kanazawa University, Ishikawa - Researchers provide details of new studies and findings in the area of enzymology
Krankenhaus der Elisabethinen, Linz - Early lymph node metastases in prostate cancer detected by SLND
Leiden University - Risk of osteoarthritis associated with high production of interleukin
M.D. Anderson Cancer Center - Adjuvant chemotherapy employed in completely resected non-small-cell lung cancer
M.D. Anderson Cancer Center - Research add new data to gene silencing body of knowledge
Max Planck Institute Biochemistry, Martinsried - Functional epigenomics identifies genes frequently silenced in prostate cancer
iCAD, Inc. - CAD detection systems provider partners for resale of fee-for-procedure product
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.